PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
17-Dec-2024 TOPTICA Photonics Inc. Participates in Federally-Funded Quantum Project TOPTICA Photonics Inc.
17-Dec-2024 Duvakitug positive phase 2b results demonstrate best-in-class potential in ulcerative colitis and Crohn’s disease Sanofi
17-Dec-2024 EyeDNA Therapeutics Receives Rare Pediatric Disease Designation from FDA for its Investigational Gene Therapy HORA-PDE6b for Patients with Retinal Dystrophy due to PDE6b Gene Mutations EyeDNA Therapeutics
17-Dec-2024 Marinomed Biotech AG: Requirements for successful completion of the restructuring proceedings achieved Marinomed Biotech AG
17-Dec-2024 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
17-Dec-2024 Availability of the Q4 2024 Aide-mémoire Sanofi
16-Dec-2024 CNX Therapeutics and Adalvo announce strategic agreement for commercialisation of Nitrofurantoin PR CNX Therapeutics
16-Dec-2024 ViiV Healthcare announces CHMP positive opinion for Vocabria + Rekambys, the first and only complete long-acting HIV treatment, for adolescents in Europe ViiV Healthcare
16-Dec-2024 GenesisCare UK successfully completes refinancing transaction and raises financing for growth GenesisCare UK
16-Dec-2024 Celltrion receives positive CHMP opinion for three biosimilars in the European Union Celltrion
16-Dec-2024 NeoPhore appoints Michael Shih as Chief Executive Officer NeoPhore
16-Dec-2024 PureTech’s Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC) PureTech
16-Dec-2024 ViroCell Biologics expands U.S. business development team with two new appointments ViroCell Biologics
16-Dec-2024 Changes in the management of SCANLAB SCANLAB
16-Dec-2024 Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU* Gerresheimer AG
16-Dec-2024 CHEPLAPHARM acquires Gemzar from Lilly Cheplapharm AG
16-Dec-2024 Large-scale SPPS capacity in Braine-l’Alleud starts production PolyPeptide Group
16-Dec-2024 Xlife Sciences AG Announces the Intended Listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 Fiscal Year Xlife Sciences AG
16-Dec-2024 Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial Relief Therapeutics Holding SA
13-Dec-2024 Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations Relief Therapeutics Holding SA